Inventor · disambiguated record
Mark Ayers
Also filed as: AYERS MARK · AYERS MARK D · AYERS MARK DAVID
7 granted patents·12 pending applications·32 citations·filing 2002–2020
80Inventor score
Top patents by PatentIndex Score
19 records- 0181US8259483B1Non-volatile memory moduleAYERS MARK·Filed 2009·Granted Sep 4, 2012·15 cites·16 claims
- 0269US7195868B2Compositions and methods for the identification, assessment, prevention, and therapy of human cancersMILLENNIUM PHARM INC·Filed 2002·Granted Mar 27, 2007·9 cites·16 claims
- 0363US7504222B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Mar 17, 2009·6 cites·15 claims
- 0456US8067189B2Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IVAYERS MARK DAVID·Filed 2006·Granted Nov 29, 2011·1 cites·2 claims
- 0553US2010009358A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0650US2010035259A1Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 0750US2007190550A1Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancersUNIV TEXAS·Filed 2006·Application pending·0 cites
- 0848US2015056191A1Igf1 biomarker for igf1r inhibitor therapyMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 0948US2022380854A1ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTSMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 1046US10222152B1Reloadable magazine apparatus configured to accept a plurality of cartridgesAYERS MARK·Filed 2018·Granted Mar 5, 2019·1 cites·19 claims
- 1146US2016312297A1Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1246US2022067050A1Hunting tag validation system that incorporates analysis of an animal sampleAYERS MARK·Filed 2020·Application pending·0 cites
- 1345US2022112564A1Gene expression based biomarker of tumor response to pd-1 antagonistsLOBODA ANDREY·Filed 2020·Application pending·0 cites
- 1444US2016312295A1Gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1544US2016304969A1Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1642US11326211B2Blood-based biomarkers of tumor sensitivity to PD-1 antagonistsMERCK SHARP & DOHME·Filed 2016·Granted May 10, 2022·0 cites·18 claims
- 1740US2005266420A1Multigene predictors of response to chemotherapyMILLENIUM PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1834US2012135875A1Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulatorsAYERS MARK DAVID·Filed 2011·Application pending·0 cites
- 1927US11377693B2System and methods for deriving gene signature biomarkers of response to PD-1 antagonistsAYERS MARK D·Filed 2015·Granted Jul 5, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Mark Ayers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →